Table 3 Univariate predictors of 6-month survival*
Characteristics | Non survivors n = 25 | Survivors n = 55 | p |
|---|---|---|---|
Characteristics at ICU admission | |||
Age | 40 ± 9 | 42 ± 9 | 0.19 |
Sex (M/F) | 8/17 | 19/36 | 0.99 |
SAPSII on admission | 55 ± 25 | 42 ± 16 | 0.02 |
Glasgow on admission | 10 ± 5 | 13 ± 4 | 0.05 |
HIV infection | |||
Initial HIV diagnosis | 8 (32) | 6 (11) | 0.03 |
Stage C | 20 (80) | 43 (78) | 0.99 |
CD4 count at admission (/mm3) | 154 ± 201 | 215 ± 198 | 0.21 |
AIDS related diagnosis at ICU admission | 16 (64) | 24 (44) | 0.15 |
Care in ICU | |||
Mechanical ventilation | 19 (76) | 20 (36) | 0.0015 |
Duration of ventilation (days) | 10 ± 13 | 3 ± 8 | 0.0001 |
Vasoactive drugs | 6 (24) | 5 (9) | 0.09 |
Duration of vasoactive drugs use (days) | 1.7 ± 2.5 | 0.6 ± 1.3 | 0.006 |
Use of HAART | |||
HAART at ICU admission | 11 (44) | 35 (64) | 0.14 |
immunovirological success at ICU admission | 3 (12) | 17 (31) | 0.096 |
HAART during ICU stay | 9 (36) | 21 (38) | 0.99 |